the current treatment landscape for patients with t-cell prolymphocytic leukemia
Published 6 months ago • 295 plays • Length 1:23Download video MP4
Download video MP3
Similar videos
-
2:18
the current landscape of treatment for bpdcn
-
6:44
the current landscape for the treatment of r/r aml in the post-transplant setting
-
1:14
an overview of the current and future treatment landscape for mpns
-
3:46
the evolving treatment landscape of r/r lbcl
-
1:06
how will novel agents & car-t cells affect the future treatment landscape in b-all?
-
1:00
insights into the future of the cll treatment landscape
-
1:28
the future of cll treatment
-
1:22
protacs: potential novel agents for the treatment of cll
-
10:11
monumental-1: talquetamab in r/r multiple myeloma
-
6:15
leucemia linfatica cronica ricaduta/refrattaria, acalabrutinib conferma il suo vantaggio a 3 anni
-
4:34
arthur's story: his cll diagnosis. challenges, treatments and future hope.
-
1:23
t-cell metabolism: a novel therapeutic avenue for gvhd
-
1:32
assessing the dynamics of cd8-expressing cells in patients with r/r lbcl treated with glofitamab
-
1:32
gvhd highlights: use of biomarkers to guide treatment
-
2:38
impact: expediting transplantation trials
-
0:52
evolving landscape of car t-cell therapies
-
1:16
current and future advancements in the treatment of cll
-
4:15
accurately assessing treatment response in pv and deciding when to switch therapies
-
3:03
the evolution of treatment patterns and prognostic biomarkers in latin american cll patients
-
3:05
the development of inkt-car t-cells for hematological malignancies
-
1:33
the current guidelines and therapies for tp53-mutated mds and aml
-
2:29
the measurement of molecular biomarkers to aid cll treatment